ADDF Grants Program
Awarded by Alzheimer's Drug Discovery Foundation (ADDF)
Purpose
To promote the research and development of technology and therapies to identify, treat and prevent cognitive decline, Alzheimer's disease and related dementias.
In addition to funding research activities, the foundation sponsors and/or co-sponsors conferences, scientific and medical workshops to advance knowledge on issues related to Alzheimer's disease and cognitive vitality.
Eligibility
There are no eligibility restrictions.
Frequency
- Dependent on funds available
There is no funding cycle
Study Length
1-3 years
Award Value
Negotiable
Application procedure
Candidates must submit a letter of intent through our online submission system at external link
Closing date
Letters of intent are accepted at any time. There are quarterly deadlines for full proposals.
Study Level
- Unrestricted
Alzheimer's Drug Discovery Foundation (ADDF)
Founded in 1998, the Alzheimer’s Drug Discovery Foundation (ADDF) is dedicated to rapidly accelerating the discovery of drugs to prevent, treat and cure Alzheimer’s disease. The ADDF is the only public charity solely focused on funding the development of drugs for Alzheimer’s, employing a venture philanthropy model to support research in academia and the biotech industry.
Contact Details
- www.alzdiscovery.org
- [email protected]
- 212.901.7997
- 212.901.7997
- 57 W 57th Street
Suit 904
New York
NY
10019
United States of America
More information
For more information regarding this award, please contact the Alzheimer's Drug Discovery Foundation (ADDF) by using the links below.
